By: Emma Andrus
42 studies with 1027 cases evaluated drugs like bimatoprost and apremilast for vitiligo.
Emma Andrus is an Assistant Editor for Dermatology Times, with a focus on dermatology and skincare topics. Her work has also been featured in AJMC - The American Journal of Managed Care, Drug Topics, TV2 KSU, and Record-Courier. Emma's articles cover a range of subjects including new drug approvals, clinical studies, treatment efficacy, and the impact of lifestyle factors on dermatological conditions.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Emma Andrus covers a wide range of topics within the healthcare and pharmaceutical industry, with a specific focus on dermatology, skin conditions, and dermatologic treatments. She heavily relies on cited data in her coverage which indicates that she values evidence-based information.
Given her emphasis on scientific themes and data-driven content, Emma is likely to be interested in pitches that offer new research findings or clinical trial results related to dermatology and skin health. Experts who can provide insights into emerging trends, innovative treatments, or breakthrough studies in these areas are likely to capture her attention.
While no geographic focus is specified for Emma's coverage, it seems she may cover global developments in the field of dermatology due to the nature of medical research being conducted internationally.
This information evolves through artificial intelligence and human feedback. Improve this profile .